StayClued

Third Rock Ventures

Not publicly disclosed in the reviewed sources. · company-creation, seed, series-a · US

US life-sciences company-creation firm with a $1.1B Fund VI.

Tier 2 · ranked #80bio

Visit / pitchOfficial siteOpen in the live directory

Key facts

Fund size$1.1B Fund VI
Stagecompany-creation, seed, series-a
Typical first checkNot publicly disclosed in the reviewed sources.
Sectorsbio, therapeutics
GeographyUS
Statusopen

Always confirm on the official page before applying — dates and terms change.

Background

US life-sciences company-creation firm with a $1.1B Fund VI. This pass separates published fund behavior from private mechanics and catalog assumptions.

How the application really works

No dedicated public pitch route was confirmed; route through a relevant investor's published professional profile or a trusted introduction.

Tips

Watch out for

Track record

No comparable acceptance rate is published.

Investment thesis

Create and build transformative biotechnology and healthcare companies.

How to reach them

Notable portfolio

Bluebird BioSage TherapeuticsRelay Therapeutics

Frequently asked questions

What stages does the fund target?
company-creation, seed, series-a
Where does it invest?
US
What is the latest disclosed vehicle or capital base?
$1.1B Fund VI
What check size does it write?
Not publicly disclosed in the reviewed sources.
How can a founder approach the firm?
No dedicated public pitch route was confirmed; route through a relevant investor's published professional profile or a trusted introduction.
What remains unknown?
Investment acceptance rate is not published. check min is not publicly disclosed. check max is not publicly disclosed. leads rounds is not publicly disclosed.

Related venture funds

Tiger Global ManagementNot publicly disclosed in the reviewed sources. · GlobalSV Angel200,000–200,000 USD · US, Global selectivelyTwo Sigma VenturesNot publicly disclosed in the reviewed sources. · US, GlobalSozo VenturesUndisclosed. · US, Japan and global companies expanding into Japan83NorthNot publicly disclosed in reviewed sources · Europe, Israel, US expansion supportSource Code CapitalUndisclosed. · China, with selective global exposure

Sources